ERBB2 and gastric cancer: Moreover, CD40 ×HER2 bsAb inhibited the cell proliferation of HER2-positive GC cells with lower IC50 (NCI-N87, 43.08 μg/mL and KATO III, 71.17 μg/mL, figure 4C).